Skip to content

The effects on circRNAs' expression in the plasma exosomes of patients with Perioperative Neurocognitive Disorders after noncardiac surgery

The effects on circRNAs' expression in the plasma exosomes of patients with Perioperative Neurocognitive Disorders after noncardiac surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038262
Enrollment
Unknown
Registered
2020-09-15
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effects on circRNAs’ expression in the plasma exosomes of patients with Perioperative Neurocognitive Disorders after noncardiac surgery

Interventions

control group:After induction of anesthesia, 0.9%NS was injected under load, and then 0.9%NS was continuously pumped into the suture.
trial group:After anesthesia induction, 0.25 mg/kg S-ketamine was injected under load, and 0.125 mg/kg/h S-ketamine was continuously pumped until the suture.

Sponsors

Guiyang Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. 60 patients scheduled for non cardiac surgery; 2. Patients older than 18 years; 3. Patients weighing 40-120kg; 5. ASA: I-III patients.

Exclusion criteria

Exclusion criteria: 1. The patient refused; 2. Patients with existing neurological or mental disorders; 3. Patients with chronic pain syndrome; 4. Patients with any acute or chronic pain treated with opioids; 5. Patients with alcohol or drug abuse; 6. Patients with rheumatoid arthritis; 7. Patients with knee joint revision surgery; 8. Patients with severe liver and kidney dysfunction; 9. Patients with severe coronary artery disease; 10. Pregnant, alcohol or opioid addicts; 11. Patients with communication difficulties and poor compliance.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;SpO2;BIS;NRS scores;TNF-a;IL-6;S100-ß;NSE;GFAP;WAIS-WMS-IV;hyperpathia;Plasma exosomes;circRNAs;

Countries

China

Contacts

Public ContactYing Cao

Guiyang Second People's Hospital

9247625@qq.com+86 13985463336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026